Tilray Canada Ltd. (“Tilray”), a wholly owned subsidiary of Tilray, Inc. (Nasdaq: TLRY) announced today that it has been selected by the Nova Scotia Liquor Corporation (“NSLC”) to receive an initial purchase order for adult-use cannabis. The purchase order would allow Tilray, one of fourteen cannabis producers selected by NSLC, to supply the province of Nova Scotia with a diverse array of cannabis products in anticipation of the launch of the adult-use market on October 17, 2018. Continue reading “Tilray® Selected by Nova Scotia Liquor Corporation to Supply a Variety of Adult-Use Cannabis Brands and Products”
Canopy Growth Corp (CGC, WEED) set the cannabis sector on fire last week after announcing a $3.8 billion investment from Constellation Brands (STZ), the third largest beer brewer in the US.
Canopy shares jumped 47% in one day on the news and almost 100% in the following week.
This week, I already see this same cycle about to repeat itself.
Whispers on the Street are speculating that a second cannabis megadeal is close at hand. Continue reading “2 Potential Cannabis Acquisition Targets for Alcohol Giant”
New mandatory marijuana pesticide testing in Colorado is putting a financial squeeze on local cultivators to the tune of thousands of dollars in increased costs.
The added expense is the latest financial blow to hit the state’s cultivators, which are already struggling with falling wholesale prices and a glut of product. Continue reading “Mandatory Testing Costly For Colorado Marijuana Growers”
The rollout Saturday of the state’s application portal for medical marijuana licenses went smoothly, with some residents noting they had been approved for their licenses earlier than expected.
Nearly 1,370 accounts had been registered and 366 patient applications and 205 commercial applications had been received by the Oklahoma Medical Marijuana Authority in the first hour after the portal went live. Continue reading “First Medical Marijuana Licenses Approved Saturday In Oklahoma”
As we have been noting in our recent coverage, the cannabis patch has been back on fire, and OrganiGram Holdings Inc (OTCMKTS:OGRMF) may represent one of the most interesting plays from here. The technicals suggest a strong potential of a new-highs breakout in the market on anything above the $4/share level, which would make it one of just a handful of stocks in the space to exceed its late-2017 highs. And the company is expanding rapidly with very strong nearly-triple-digit sales growth. Continue reading “OrganiGram Holdings Inc (OTCMKTS:OGRMF) Goes Coast to Coast”
The Cannabis sector just delivered its best day of the year after the third largest US beer brewer invested a record $3.8 billion in the largest cannabis company in the world.
Canopy Growth Corp (CGC), the largest cannabis company in the world, set the cannabis sector on fire last week after announcing a groundbreaking deal.
Constellation (STZ), the third largest US beer company and brewer of Corona, invested $3.8 billion into Canopy in the largest deal ever in the cannabis sector. Continue reading “Canopy Jumps 47% in One Day – Sets Stage for Next Huge Cannabis Rally”
Canopy Growth Corp (NYSE: CGC) has shot up more than 30% over the last 30 days – albeit most of it on the back of one announcement, but that single bit of news caused a tidal wave across the cannabis industry. CGC received a huge endorsement from Constellation Brands, an alcoholic beverage titan who owns the likes of Corona and other popular brands in the industry. Continue reading “Constellation and Canopy Growth Corp (NYSE: CGC) Bet Big on Global Cannabis”
This Offer Has Expired
During your free month, you’ll have access to my:
This diversified portfolio consists of longer-term investments based on fundamentals and shorter-term trades based on technical chart formations and momentum. Continue reading “This Week Only – Free Month of CST”
A group of Michigan legislators wants to prevent a scheduled shutdown of many of the state’s medical marijuana businesses.
At issue, the band of nine Democrats and one Republican says, is a “significant backlog” of licensing applications from marijuana businesses, some of which applied prior to Feb. 15. Continue reading “Lawmakers ask governor to halt scheduled shutdown of Michigan medical marijuana facilities”
U.K. company GW Pharmaceuticals has revealed how much their new epilepsy drug Epidiolex will cost. Epidiolex was approved for use in the U.S. by the Food and Drug Administration in June. The drug is the first medication derived from cannabis to receive approval from the agency. Continue reading “Pharmaceutical Company Reveals Cost of FDA-Approved Cannabis Based Medicine”